Budapest, Hungary

Zsuzsanna Tegyei

This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zsuzsanna Tegyei. Retrieved from https://idiyas.com/inventor/zsuzsanna-tegyei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zsuzsanna Tegyei: Innovator in CNS Activity Derivatives

Introduction

Zsuzsanna Tegyei is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of chemistry, particularly in the development of compounds with central nervous system (CNS) activity. Her work has implications for various therapeutic applications.

Latest Patents

Zsuzsanna Tegyei holds a patent for N4-Substituted tetrahydro-1,2,4-oxadiazin-5-one derivatives. This invention relates to new tetrahydro-1,2,4-oxadiazin-5-one derivatives that exhibit CNS activity. More specifically, the patent concerns new N.sup.4-substituted tetrahydro-1,2,4-oxadiazin-5-ones of the formula (1), wherein R.sup.2 is benzyloxycarbonyl or alkylcarbonyl containing 1 to 4 carbon atoms in the alkyl moiety, preferably acetyl. This innovation represents a step forward in the search for effective CNS-active compounds.

Career Highlights

Zsuzsanna Tegyei is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. Her role in the company has allowed her to focus on research and development in the field of medicinal chemistry. With her expertise, she has contributed to advancing the understanding of CNS-active compounds.

Collaborations

Zsuzsanna has collaborated with notable colleagues, including Laszlo Urogdi and Agnes Patthy Nee Lukats. These collaborations have fostered a productive research environment, leading to innovative discoveries in their field.

Conclusion

Zsuzsanna Tegyei's work in developing N4-Substituted tetrahydro-1,2,4-oxadiazin-5-one derivatives highlights her contributions to medicinal chemistry and CNS activity research. Her innovative spirit and collaboration with esteemed colleagues continue to drive advancements in this important area of study.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…